Name | Bevacizumab | CAS# | 216974-75-3 | |
---|---|---|---|---|
Price | ¥Inquiry/1g | Purity | 98.9% | |
Stocking Period |
1 Day | Stock | In Stock |
Detail
Product Information
Bevacizumab (anti-VEGF) is a humanized anti-VEGF monoclonal antibody which binds to and neutralizes all human VEGF-A isoforms and bioactive proteolytic fragments. |
Get all suppliers by the below link:
2024-07-15 |
Bevacizumab
Price: Inquiry |
2020-12-18 |
Bevacizumab
Price: $450.0 |
2023-11-15 |
Bevacizumab
Price: ¥Inquiry |
2022-05-12 |
Bevacizumab
Price: $Inquiry |
2023-05-17 |
Bevacizumab
Price: ¥Inquiry |
2023-04-03 |
Bevacizumab
Price: $Inquiry |
2023-10-30 |
Bevacizumab
Price: ¥Inquiry |
2022-09-23 |
Bevacizumab
Price: ¥3000.0 |
2023-02-09 |
Bevacizumab
Price: ¥Inquiry |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved